This inventor holds 21 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Ligand Pharmaceuticals, Inc., Phenomix Corporation, Forest Laboratories Holdings Limited (Bm). Active years: 1996-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
10 out of 139 
8 out of 9 
2 out of 2 Years Active: 1996-2013
Areas of Expertise:
Title: The Innovative Contributions of David T. Winn
Introduction
David T. Winn, an accomplished inventor based in San Diego, CA, has made significant contributions to the field of pharmaceuticals through his innovative approaches and discoveries. With a total of 21 patents, Winn’s work reflects a commitment to developing solutions for critical health issues, particularly in diabetes treatment.
Latest Patents
Among his latest patents is the groundbreaking work on heterocyclic boronic acid compounds. This invention focuses on Dipeptidyl peptidase IV (DPP-IV)-inhibiting compounds designed to aid in the treatment of Type II diabetes and other related diseases. The patent details a formula that involves specific components such as X being CHS, O, or C, and various substituents to enhance the compounds' efficacy. Additionally, the methods for preparing these compounds involve innovative pharmaceutical compositions that may include combinations with other antidiabetic agents.
Another notable patent by Winn encompasses activity-based probes (ABPs) and methods for their preparation and use. This invention provides new ways to evaluate the profiles of catalytically active enzymes in protein-containing samples. The methods utilize ABPs designed with specific binding affinities and reactive groups to form covalent bonds with target enzymes. This invention holds promise in understanding and assessing enzyme profiles in various biological contexts.
Career Highlights
David T. Winn has built a distinguished career working with prominent organizations such as Ligand Pharmaceuticals and Phenomix Corporation. His tenure at these companies has enabled him to collaborate with a network of professionals and contribute to significant advancements in medical research and therapeutics.
Collaborations
Throughout his career, Winn has collaborated with talented individuals, including coworkers David Alan Campbell and Juan Manuel Betancort. Together, they have worked on various projects that leverage their combined expertise to enhance pharmaceutical development and innovation.
Conclusion
David T. Winn stands out as a prolific inventor whose work plays a critical role in advancing medical science. His 21 patents highlight a commitment to innovation that addresses pressing health challenges, particularly in the realm of diabetes treatment. As he continues to make strides in pharmaceuticals, his contributions are sure to leave a lasting impact on the industry and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile